Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Aditya Soni and Kenneth Li SAN FRANCISCO/NEW YORK, Sept 22 (Reuters) - Companies betting…
LATVIAN PRIME MINISTER SAYS MACRON HAS AGREED TO START TALKS WITH LATVIA ON JOINING FRANCE'S…
By Rajasik Mukherjee and Kumar Tanishk Sept 22 (Reuters) - IDP Education on Tuesday rejected…
Sept 22 (Reuters) - Votum SA: * H1 NET PROFIT 56.9 MILLION ZLOTYS * H1…
UNITED NATIONS, Sept 22 (Reuters) - President Donald Trump on Tuesday said US government documents…
SWISS FINANCE MINISTER: GOVERNMENT AND SWISS NATIONAL BANK SEEK FULL BACKING (The article has been…